Amgen logo

Amgen Business Segments

Business, geographic, and product segment breakdowns

Amgen generates $37.2B in annual revenue across 2 key segments: TAVNEOS ($2.4B), and TAVNEOS, US Market ($2.3B). The company-wide operating margin is 28.39%. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$183.12B
P/E Ratio23.48
ROE101.32%

Products & Services